Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,774.00
Ask: 1,774.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Bernstein Raises Tesco And Cuts Morrisons

Mon, 08th Sep 2014 08:35

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:
----------
FTSE 100
----------
BERNSTEIN RAISES TESCO TO 'MARKET-PERFORM' ('UNDERPERFORM') - PRICE TARGET 235 PENCE
----------
BERNSTEIN CUTS MORRISON TO 'UNDERPERFORM' ('MARKET-PERFORM') - PRICE TARGET 140 (180) PENCE
----------
CS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1400 (1475) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK RAISES BARCLAYS PRICE TARGET TO 300 (285) PENCE - 'BUY'
----------
JPMORGAN RAISES BARRATT DEVELOPMENTS TO 'OVERWEIGHT.' ('NEUTRAL') - PT 460 (440) PENCE
----------
JPMORGAN RAISES INTU PROPERTIES PRICE TARGET TO 340 (305) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES PERSIMMON PRICE TARGET TO 1650 (1570) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS DIAGEO PRICE TARGET TO 1730 (1760) PENCE - 'UNDERWEIGHT'
----------
HSBC CUTS HARGREAVES LANSDOWN PRICE TARGET TO 850 (950) PENCE - 'UNDERWEIGHT'
----------
CITIGROUP RAISES RECKITT BENCKISER PRICE TARGET TO 6000 (5700) PENCE - 'BUY'
----------
FTSE 250
----------
JEFFERIES RAISES BODYCOTE PRICE TARGET TO 835 (825) PENCE - 'BUY'
----------
LIBERUM RAISES CARILLION PRICE TARGET TO 440 (420) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS PREMIER OIL PRICE TARGET TO 420 (495) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS AFREN PRICE TARGET TO 130 (175) PENCE - 'HOLD'
----------
JPMORGAN RAISES BELLWAY PRICE TARGET TO 2100 (2000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES BERKELEY GROUP PRICE TARGET TO 2900 (2800) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES BOVIS HOMES PRICE TARGET TO 1000 (950) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS REDROW PRICE TARGET TO 330 (365) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES JLT GROUP PRICE TARGET TO 1260 (1180) PENCE - 'OVERWEIGHT'
----------
CITIGROUP CUTS SYNERGY HEALTH TO 'NEUTRAL' ('BUY') - TARGET 1600 (1145) PENCE
----------
NUMIS RAISES JUPITER FUND TO 'BUY' ('ADD') - TARGET 480 (475) PENCE
----------
NUMIS CUTS KAZAKHMYS PRICE TARGET TO 280 (290) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
DEUTSCHE BANK CUTS SALAMANDER ENERGY TO 'HOLD' ('BUY') - TARGET 125 (185) PENCE
----------
JPMORGAN CUTS LONDON MINING TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 27 (100) PENCE
----------
CANACCORD CUTS CHARLES STANLEY GROUP PRICE TARGET TO 385 (480) PENCE - 'BUY'
----------
CITIGROUP CUTS LAMPRELL TO 'NEUTRAL' ('BUY') - TARGET 177 PENCE
----------
NUMIS CUTS PETROPAVLOVSK PRICE TARGET TO 30 (60) PENCE - 'SELL'
----------
NUMIS RAISES RIVER & MERCANTILE PRICE TARGET TO 238 (235) PENCE - 'ADD'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.